|
Merck Half-Year Financial Report Q2_2011 |
35 pages |
1.2 MB |
|
At a glance |
1 page |
623 kB |
|
Merck shares |
1 page |
669 kB |
|
Merck Group |
5 pages |
706 kB |
|
Pharmaceuticals |
5 pages |
710 kB |
|
Chemicals |
5 pages |
710 kB |
|
Financial Statements |
14 pages |
755 kB |
|
Other |
2 pages |
563 kB |
|
|
|
|
|
The following XLS files are available |
|
All tables (22) of the Interim Report (indexed) |
109 kB |
|
Key figures – 2nd quarter 2011 |
16 kB |
|
Components of growth by division – Q2 |
15 kB |
|
Share data |
16 kB |
|
Merck Serono | Key figures |
15 kB |
|
Consumer Health Care | Key figures |
15 kB |
|
Merck Millipore | Key figures |
15 kB |
|
Performance Materials | Key figures |
15 kB |
|
Corporate and Other | Key figures |
15 kB |
|
Income Statement of the Merck Group |
18 kB |
|
Balance Sheet of the Merck Group |
19 kB |
|
Segment Reporting of the Merck Group – Pharmaceuticals |
21 kB |
|
Segment Reporting of the Merck Group – Chemicals |
22 kB |
|
Segment Reporting of the Merck Group – Corporate and Other/Merck Group |
21 kB |
|
Cash Flow Statement of the Merck Group |
18 kB |
|
Free Cash Flow of the Merck Group |
16 kB |
|
Statement of Comprehensive Income of the Merck Group |
17 kB |
|
Statement of Changes in Net Equity including Non-Controlling Interest of the Merck Group |
18 kB |
